TITLE

Treatment of Chronic Hepatitis B in the Human Immunodeficiency Virus--Infected Patient: Present and Future

AUTHOR(S)
Núñez, Marina; Puoti, Massimo; Camino, Nuria; Soriano, Vincent
PUB. DATE
December 2003
SOURCE
Clinical Infectious Diseases;12/15/2003, Vol. 37 Issue 12, p1678
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The management of chronic hepatitis B poses specific problems in the presence of human immunodeficiency virus (HIV) coinfection, because therapeutic approaches have to address both hepatitis B virus (HBV) and HIV infections. Response to interferon (IFN-α) is lower in HBV-HIV--coinfected than in HIV-negative subjects, especially in patients in advanced stages of immunosuppression. Thus far, there are no data on the performance of the new pegylated forms of IFN-α in HBV- and HIV--coinfected persons. After prolonged use of lamivudine, resistance develops in the majority of HBV-HIV--coinfected patients treated with the drug. The more recently approved tenofovir has shown excellent short-term results, and data from longer follow-up studies are eagerly awaited. Several drugs with combined anti-HIV and anti-HBV activity have recently been approved (emtricitabine) or are currently under development. Preliminary results with some of them are quite promising and probably will widen the therapeutic armamentarium against hepatitis B in patients with HIV infection.
ACCESSION #
11770252

 

Related Articles

  • Immunologic and Clinical Responses to Highly Active Antiretroviral Therapy in Patients with HIV Infection Aged >50 Years. Cuzin, Lise; Delpierre, Cyrille; Gerard, Stéphane; Massip, Patrice; Marchou, Bruno // Clinical Infectious Diseases;9/1/2007, Vol. 45 Issue 5, p654 

    We analyzed the effect of age on highly active antiretroviral therapy efficacy and tolerance in 639 patients with human immunodeficiency virus (HIV) infection (99 of whom were aged >50 years, and 540 of whom were aged <50 years). Late testing, which was more frequent in the older age group, was...

  • Rising prevalence of variant HIV-1 subtypes poses new diagnostic challenge. Robinson, John M. // MLO: Medical Laboratory Observer;Jul2007, Vol. 39 Issue 7, p28 

    The article focuses on the diagnostic challenge posed by the increasing prevalence of variant HIV-1 infection subtypes. Study shows that infections may represent up to 10 percent of HIV-1 infections in the U.S. They have significant implications for HIV- diagnostics and therapy. Another study...

  • Screening for and Treating Hepatitis B Virus in Patients with HIV Infection. Tillmann, Hans L. // Clinical Infectious Diseases;9/1/2007, Vol. 45 Issue 5, p633 

    The author reflects on the importance of diligent screening for hepatitis B virus (HBV) in the context of human immunodeficiency virus (HIV) infection. He remarks that while treatment for patients coinfected with HBV and HIV based on the study describes within the issue, he argues that...

  • Human Immunodeficiency Virus Infection Does Not Alter Serum Transaminases and Hepatitis B Virus (HBV) DNA in Homosexual Patients with Chronic HBV Infection. Bonacini, Maurizio; Govindarajan, Sugantha; Redeker, Allan G. // American Journal of Gastroenterology;May1991, Vol. 86 Issue 5, p570 

    The influence of human immunodeficiency virus (HIV) infection on the clinical course of chronic hepatitis B virus (HBV) infection is controversial. We followed a cohort of 64 homosexual men with persistent HBs antigenemia for a median of 24 months in the hepatitis clinic of a large urban public...

  • Impact of Chronic Hepatitis B Virus (HBV) Infection on Outcomes of Patients Infected with HIV in an Area Where HBV Infection Is Hyperendemic. Sheng, Wang-Huei; Chen, Mao-Yuan; Hsieh, Szu-Min; Hsiao, Chin-Fu; Wang, Jann-Tay; Hung, Chien-Ching; Chang, Shan-Chwen // Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1471 

    Between June 1994 and February 2003, a total of 111 human immunodeficiency virus (HIV)-infected patients with chronic hepatitis B virus (HBV) coinfection and 387 HIV-infected patients without HBV or hepatitis C virus coinfection were prospectively observed to assess the impact of HBV infection...

  • Impact of Hepatitis B Virus Infection on Human Immunodeficiency Virus Response to Antiretroviral Therapy in Nigeria. Idoko, John; Meloni, Seema; Muazu, Mohammed; Nimzing, Ladep; Badung, Bitrus; Hawkins, Claudia; Sankalé, Jean-Louis; Ekong, Ernest; Murphy, Robert; Kanki, Phyllis; Thio, Chloe L. // Clinical Infectious Diseases;10/15/2009, Vol. 49 Issue 8, p1268 

    Background. As highly active antiretroviral therapy (ART) is introduced into areas of the world in which hepatitis B virus (HBV) infection is highly endemic, it is important to determine the influence of HBV on persons with human immunodeficiency virus (HIV) and HBV coinfection who are receiving...

  • Infection Control in Jails and Prisons. Bick, Joseph A. // Clinical Infectious Diseases;10/15/2007, Vol. 45 Issue 8, p1047 

    At the end of 2005, ∼7 million people (or 1 of every 33 American adults) were either in jail, in prison, or on parole [1]. Compared with the general public, newly incarcerated inmates have an increased prevalence of human immunodeficiency virus infection, hepatitis B virus infection,...

  • BELIEF IN A CURE FOR HIV INFECTION ASSOCIATED WITH GREATER HIV RISK BEHAVIOUR AMONG HIV POSITIVE MEN WHO HAVE SEX WITH MEN. Misovich, Stephen J.; Fisher, Jeffrey D.; Fisher, William A. // Canadian Journal of Human Sexuality;Winter99, Vol. 8 Issue 4, p241 

    The increasingly prevalent belief that HIV infection can now be cured through highly active antiretroviral therapy (HAART) regimens may contribute to elevated levels of HIV risk behaviours among HIV seropositive individuals. This study assessed the extent to which a sample of HIV seropositive...

  • Researchers Devise Method for Natural Killer Cells to Destroy Hiding HIV.  // Ascribe Newswire: Medicine;5/19/2004, p141 

    Mayo Clinic researchers have identified a way to manipulate the body's own natural killer cells to destroy cells containing the HIV virus. Current treatments for HIV block the virus from replicating, but don't kill the cells that contain HIV. The existence of these HIV-harboring cells, often...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics